ST5 Antikörper (Middle Region)
-
- Target Alle ST5 Antikörper anzeigen
- ST5 (Suppression of Tumorigenicity 5 (ST5))
-
Bindungsspezifität
- AA 571-586, Middle Region
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ST5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit IgG polyclonal antibody for Suppression of tumorigenicity 5 protein(ST5) detection. Tested with WB in Human,Mouse,Rat.
- Sequenz
- KRHSHDDMLL LAQLSL
- Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
- Produktmerkmale
-
Rabbit IgG polyclonal antibody for Suppression of tumorigenicity 5 protein(ST5) detection. Tested with WB in Human,Mouse,Rat.
Gene Name: suppression of tumorigenicity 5
Protein Name: Suppression of tumorigenicity 5 protein - Aufreinigung
- Immunogen affinity purified.
- Immunogen
- A synthetic peptide corresponding to a sequence in the middle region of human ST5(571-586aa KRHSHDDMLLLAQLSL), different from the related mouse and rat sequences by one amino acid.
- Isotyp
- IgG
- Top Product
- Discover our top product ST5 Primärantikörper
-
-
- Applikationshinweise
-
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human, Mouse, Rat
Notes: Tested Species: Species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities.
Other applications have not been tested. Optimal dilutions should be determined by end users. - Kommentare
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- Konzentration
- 500 μg/mL
- Buffer
- Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
- Konservierungsmittel
- Thimerosal (Merthiolate), Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
-
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
-
- Target
- ST5 (Suppression of Tumorigenicity 5 (ST5))
- Andere Bezeichnung
- ST5 (ST5 Produkte)
- Synonyme
- zgc:91902 antikoerper, wu:fc11b09 antikoerper, si:ch211-208c6.1 antikoerper, ST5 antikoerper, DKFZp459D1230 antikoerper, hts1 antikoerper, p126 antikoerper, dennd2b antikoerper, DENND2B antikoerper, HTS1 antikoerper, 2010004M01Rik antikoerper, 2610305K15Rik antikoerper, suppression of tumorigenicity 5 antikoerper, st5 antikoerper, ST5 antikoerper, St5 antikoerper
- Hintergrund
-
Suppression of tumorigenicity 5 is a protein that in humans is encoded by the ST5 gene. This gene is mapped to 11p15.4. The protein encoded by this gene contains a C-terminal region that shares similarity with the Rab 3 family of small GTP binding proteins. This protein preferentially binds to the SH3 domain of c-Abl kinase, and acts as a regulator of MAPK1/ERK2 kinase, which may contribute to its ability to reduce the tumorigenic phenotype in cells. Three alternatively spliced transcript variants of this gene encoding distinct isoforms are identified.
Synonyms: DENN domain containing protein 2B antibody|DENN domain-containing protein 2B antibody|DENN/MADD domain containing 2B antibody|DENND2B antibody|HeLa tumor suppression 1 antibody|HTS1 antibody|p126 antibody|ST 5 antibody|ST5 antibody|Suppression of tumorigenicity 5 antibody|Suppression of tumorigenicity 5 protein antibody - UniProt
- P78524
-